See also this year's filing and all EDGAR filings for this company.
PDF Report 0001867096_2026_Xeris_Biopharma_Holdings_Inc.pdf
Logs
Graph
Absolute values for 0001867096, Xeris Biopharma Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 240,313,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 110,937,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,945,000 |
| 3 | remainder_Assets | 27,332,000 |
| 4 | LiabilitiesCurrent | 109,574,000 |
| 5 | LiabilitiesNoncurrent | 260,264,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 185,140,253 |
| 9 | ResearchAndDevelopmentExpense | 30,502,707 |
| 10 | remainder_Expenses | 72,412,259 |
| 11 | remainder_Revenues | 735,123,731 |
| 12 | remainder_NetIncome | -26,411,199 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 383,527,000 |
| 1 | Liabilities | 369,838,000 |
| 2 | Expenses | 288,055,219 |
| 3 | Revenues | 735,123,731 |
| 4 | StockholdersEquity | 13,689,000 |
| 5 | NetIncome | 420,657,313 |
| 6 | ComprehensiveNetIncome | 420,657,313 |
| 7 | BaseVar | 901,477,574 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.20 |
| 9 | EconomicCapitalRatio | 2.45 |